Ozempic delivers higher semaglutide exposure, so switching to Rybelsus may result in less glycemic control and less weight loss
Svensson J, Lall S, Dickson SL, Bengtsson BA, Rmer J, Ahnfelt-Rnne I, Ohlsson C, Jansson JO
But as Ive seen while supporting family members on GLP-1 medications, the reality is much more nuancedand much more personal
Those with type 1 diabetes should not be prescribed semaglutide injections, along with anyone who is at a higher risk or has a family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 due to any further increase of risk that could be caused by the injections
There are clear reasons why this happens: Appetite increases